| KARYOPHARM THERAPEUTICS |
| USA |
| Gesundheit |
| US48576U2050 / A40YLC |
| 25K0 (Frankfurt) / KPTI (NASDAQ) |
| FRA:25K0, ETR:25K0, 25K0:GR, NASDAQ:KPTI |
| - |
| https://www.karyopharm.co.. |
|
Karyopharm Therapeutics Inc. is a biopharmaceutica..
>Volltext.. |
| 97.1 Mio. EUR |
| 225.54 Mio. EUR |
| 119.78 Mio. EUR |
| -87.22 Mio. EUR |
| -104.73 Mio. EUR |
| -12.25 EUR |
| 165.07 Mio. EUR |
| 31.66 Mio. EUR |
| -75.09 Mio. EUR |
| 0.53 |
| -8.89% |
| -35.17% |
| - |
| - |
| - |
| KARYOPHARM |
| 13.02.26 |
|
||||
|